Dietary Factors Linked to Changes in Gastric Cancer Risk

Article

A meta-analysis found that a number of dietary factors play a role in the risk of developing gastric cancer, with protective effects seen with fruit and certain vegetables and increased risk seen with high-salt foods and certain forms of alcohol.

Image © R.Iegosyn / Shutterstock.com

A meta-analysis found that a number of dietary factors play a role in the risk of developing gastric cancer, with protective effects seen with fruit and certain vegetables and increased risk seen with high-salt foods and certain forms of alcohol.

“The decreasing incidence of gastric cancer in developed countries may be partly the results of increased use of refrigeration, availability of fresh fruit and vegetables, and decreased reliance on salted or preserved foods,” wrote study authors led by Xuexian Fang, of Zhejiang University in Hangzhou, China. Numerous studies have looked at various dietary factors as they relate to gastric cancer, and the new study aimed to provide a collective assessment of the relationships.

A total of 76 prospective cohort studies were included, encompassing 32,758 gastric cancer cases among 6,316,385 total participants. The studies covered 67 distinct dietary factors and ranged in follow-up from 3.3 to 30 years. The results were published online ahead of print in the European Journal of Cancer.

The analysis found several factors significantly related to gastric cancer risk. For example, consumption of white vegetables had a protective effect, with a relative risk (RR) of 0.67 (95% confidence interval [CI], 0.47–0.95). Consumption of all vegetables, however, did not yield a significant effect. Consumption of total fruit did yield such an effect, with an RR of 0.93 (95% CI, 0.89–0.98).

On the other hand, consumption of pickled vegetables, tomatoes, and spinach were each associated with increased risk for gastric cancer.

Certain types of meat were also associated with an increased risk, though total meat was not. Processed meat yielded an RR of 1.15 (95% CI, 1.03–1.29), and ham, bacon, and sausage collectively had an RR of 1.21 (95% CI, 1.01–1.46). The most substantial effect was seen with high-salt foods, with an RR of 1.55 (95% CI, 1.17–2.05).

Overall alcohol consumption also raised the risk for gastric cancer, with an RR of 1.15 (95% CI, 1.01–1.31). Beer and liquor consumption in particular raised the risk, while wine did not.

On a dose response analysis, every 5 grams per day increment of dietary salt intake raised the risk by 12%. Each 10 grams per day increment of alcohol consumption raised one’s risk by 5%, and a 100 gram per day increment of fruit consumption lowered the risk by 5%.

“Our results provide further support for public health recommendations to increase the intake of dietary fruits and white vegetables, while reducing intake of high-salt food, beer and liquor, in the prevention of gastric cancer,” the authors concluded. “These findings may also provide valuable insights into further cohort studies and the design of informative clinical trials.”

Related Videos
Tailoring neoadjuvant therapy regimens for patients with mismatch repair deficient gastroesophageal cancer represents a future step in terms of research.
Not much is currently known about the factors that may predict pathologic responses to neoadjuvant immunotherapy in this population, says Adrienne Bruce Shannon, MD.
The toxicity profile of tislelizumab also appears to look better compared with chemotherapy in metastatic esophageal squamous cell carcinoma.
Patients with unresectable or metastatic esophageal squamous cell carcinoma and higher PD-L1 expression may benefit from treatment with tislelizumab, according to Syma Iqbal, MD.
Quantifying disease volume to help identify potential recurrence following surgery may be a helpful advance, according to Sean Dineen, MD.
Tanios S. Bekaii-Saab, MD, and the Oncology Brothers presenting slides
Tanios S. Bekaii-Saab, MD, and the Oncology Brothers presenting slides
Tanios S. Bekaii-Saab, MD, and the Oncology Brothers presenting slides
Tanios S. Bekaii-Saab, MD, and the Oncology Brothers presenting slides
Adrienne Bruce Shannon, MD, discussed ways to improve treatment and surgical outcomes for patients with dMMR gastroesophageal cancer.